Stay updated with breaking news from Nasdaq Cdtx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) have received an average rating of “Buy” from the four brokerages that are presently covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year […]
Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) gapped up prior to trading on Thursday after Needham & Company LLC raised their price target on the stock from $3.00 to $25.00. The stock had previously closed at $12.29, but opened at $14.50. Needham & Company LLC currently has a buy rating on the […]
Cidara Therapeutics (NASDAQ:CDTX – Get Free Report)‘s stock had its “strong-buy” rating reiterated by stock analysts at WBB Securities in a note issued to investors on Thursday, Benzinga reports. They currently have a $40.00 price target on the biotechnology company’s stock. WBB Securities’ price target would indicate a potential upside of 207.69% from the stock’s […]
Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) have received a consensus recommendation of “Buy” from the four analysts that are presently covering the company, MarketBeat reports. Three analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average twelve-month price target […]
Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) have received an average recommendation of “Buy” from the four brokerages that are presently covering the firm, Marketbeat Ratings reports. Three investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1 […]